文献速递抗菌药物管理

优化肺炎出院时抗菌治疗疗程的方案评估

Evaluation of a protocol to optimize duration of pneumonia therapy at hospital discharge.
PubMed 文献 · Am J Health Syst Pharm · 2016-11-02

该回顾性准实验研究在Boise退伍军人事务医疗中心开展,评估药师主导的肺炎出院抗菌治疗疗程分诊算法对疗程及30天再入院率的影响。结果显示干预与人均月疗程斜率显著降低相关(p=0.03),平均疗程从9.5天降至8.2天,且未对30天再入院率产生负面影响。

要点

  • 药师分诊算法可减少肺炎出院时过长的抗菌治疗疗程
  • 干预后平均疗程由9.5天降至8.2天,主要来自门诊疗程缩短
  • 30天再入院率未因疗程缩短而增加

核心结论

  • 基于药师的肺炎出院疗程分诊算法有助于减少过长的抗菌治疗疗程,且未对30天再入院率产生负面影响。

研究设计与样本

  • 回顾性准实验研究,2013年3月至2015年6月在Boise退伍军人事务医疗中心开展。
  • 共707例出院诊断为肺炎的患者,560例符合纳入标准(干预前366例,干预后194例)。
  • 干预包括制定肺炎疗程分诊算法、药师评估适当疗程的流程及向处方者提出限制过长出院疗程的建议。
  • 采用中断时间序列分析评估人均月疗程和30天再入院率。

主要发现

  • 干预后人均月疗程斜率较干预前显著降低(p=0.03),提示干预与人均疗程相关。
  • 干预与30天再入院率无关联。
  • 平均±标准差疗程从干预前9.5±2.4天降至干预后8.2±2.9天。
  • 门诊疗程从干预前5.2±3.0天降至干预后4.2±3.0天,为主要缩短来源。

临床怎么用

  • 临床药师可参与制定并执行肺炎出院疗程分诊算法,评估并建议限制过长的出院抗菌治疗疗程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: A protocol to optimize the duration of antimicrobial therapy (DAT) for uncomplicated pneumonia at hospital discharge was evaluated. METHODS: This retrospective quasiexperimental study was conducted at Boise Veterans Affairs Medical Center from March 2013 through June 2015. Patients were included in the study if they were diagnosed with pneumonia, were hospitalized for more than 24 hours, received antimicrobial treatment within 48 hours of admission, and survived until hospital discharge. The intervention included development of a pneumonia DAT triage algorithm, a process for assessment of the appropriate DAT by pharmacists, and recommendations to providers to limit excessive discharge DATs prescribed. Interrupted time-series analysis was performed to determine the mean monthly DAT per patient and the 30-day readmission rate. RESULTS: Of the 707 patients discharged with a diagnosis of pneumonia, 560 met the criteria for study inclusion (366 in the preimplementation group and 194 in the postimplementation group). Change in slope of monthly mean DAT per patient postimplementation was significantly reduced (p = 0.03) from the preimplementation slope (p = 0.95), indicating an association between the intervention and mean DAT per patient. The intervention was not associated with the 30-day readmission rate. The mean ± S.D. DAT decreased from 9.5 ± 2.4 days preimplementation to 8.2 ± 2.9 days postimplementation, primarily due to the reduction of outpatient DAT from 5.2 ± 3.0 days preimplementation to 4.2 ± 3.0 days postimplementation. CONCLUSION: A pharmacy-based triage algorithm helped to reduce excessive DATs for patients with pneumonia at hospital discharge without negatively affecting 30-day readmission rates.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Caplinger C, Crane K, Wilkin M, et al. Evaluation of a protocol to optimize duration of pneumonia therapy at hospital discharge. Am J Health Syst Pharm. 2016. PMID: 27806937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。